On 2026-03-04 08:32:45 (Saudi Time), Dr. Soliman Abdel Kader Fakeeh Hospital Co. announced its Annual financial results for the twelve months ended on December 31, 2025.

Element List	Explanation
The reason of the increase (decrease) in the sales/ revenues during the current year compared to the last year	Group revenue for the current year increased by 11% to SAR 3,091 million, compared with SAR 2,791 million in the previous year. This growth was primarily driven by an 8% increase in the number of patients served to 1.9 million, supported by continued demand across the Group’s network, particularly at its ramping-up hospitals in Riyadh and Madinah through the introduction and deepening of specialty services. Growth was also supported by the expansion in operational capacity at Group level, with operational beds increasing to 544 in 4Q25 from 457 in 4Q24, mainly driven by capacity additions at DSFH Riyadh and the phased opening of DSFH Madinah. Revenue growth further benefited from continued improvement in case mix toward higher-value, complex care.
The reason of the increase (decrease) in the net profit during the current year compared to the last year is	EBITDA for 2025 amounted to SAR 496 million, compared with SAR 522 million in the previous year. The year-on-year movement mainly reflects the ramp-up impact of DSFH Madinah, where front-loaded clinical capacity, operating readiness costs, and fixed overhead were carried ahead of full occupancy. Excluding DSFH Madinah’s impact, Group EBITDA would have increased to SAR 560 million compared with SAR 528 million in the previous year. Profit attributable to shareholders remained resilient at SAR 290 million in FY25, supported by growth in the Mature Business and uplift from DSFH Riyadh as it progressed further along its breakeven trajectory. Excluding DSFH Madinah's impact, attributable profits to shareholders would have increased by 14% year on year to SAR 332 million. This provides clear visibility on the underlying earnings strength of Fakeeh Care Group and the impact from facilities still in the early stages of ramp-up.
Statement of the type of external auditor's report	Unmodified opinion
Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion)	Not Applicable
Reclassification of Comparison Items	Certain comparative figures have been reclassified, wherever considered necessary, for the purpose of comparison and better presentation.
Additional Information	Not Applicable
Attached Documents

Year-on-Year Performance Drivers

Sales increased 10.73% YoY to SAR 3,090.25 million, driven by an 8% increase in patients served to 1.9 million and expanded operational capacity from 457 to 544 beds, particularly at ramping-up hospitals in Riyadh and Madinah. Net profit remained relatively stable with a modest 0.91% increase to SAR 290.18 million, as revenue growth was offset by ramp-up costs and front-loaded expenses at DSFH Madinah, including clinical capacity investments and fixed overhead carried ahead of full occupancy.

Other Items

The auditors issued an unmodified opinion with no additional comments, disclaimers, or adverse remarks noted. The company reported revenue growth of 10.73% to SAR 3,090.25 million driven by expanded operational capacity and improved case mix toward higher-value complex care. Net profit attributable to shareholders increased marginally by 0.91% to SAR 290.18 million, with EBITDA declining to SAR 496 million from SAR 522 million due to ramp-up costs at DSFH Madinah facility. Total shareholders equity grew 7.7% to SAR 3,172.03 million, while earnings per share decreased slightly from SAR 1.32 to SAR 1.26.

Original announcement:

Attached PDF document link:

Important Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.